Location: New York, NY
CIK: 0001482416 · Show all filings
Period: Q2 2022 (← Previous) (Next →)
Filing Date: Aug 15, 2022
Total Value: $266M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| COR | AMERISOURCEBERGEN CORP | 183,334 | $25.94M | 9.7% | $133.79 | +10.4% | COM | 03073E105 |
| — | MEDICUS SCIENCES ACQUISITION | 2,323,000 | $22.72M | 8.5% | $9.72 | — | CL A SHS | G5960S108 |
| OGN | ORGANON & CO | 574,855 | $19.4M | 7.3% | $29.51 | 0.0% | COMMON STOCK | 68622V106 |
| CI | CIGNA CORP | 53,034 | $13.98M | 5.2% | $187.09 | +29.0% | COM | 125523100 |
| INGN | INOGEN INC | 525,438 | $12.71M | 4.8% | $31.10 | -14.6% | COM | 45780L104 |
| BCYC | BICYCLE THERAPEUTICS PLC | 688,989 | $11.56M | 4.3% | $20.16 | — | SPONSORED ADS | 088786108 |
| CNC | CENTENE CORP | 129,011 | $10.92M | 4.1% | $67.69 | +22.7% | COM | 15135B101 |
| HCA | HCA HEALTHCARE INC | 61,953 | $10.41M | 3.9% | $208.06 | 0.0% | COM | 40412C101 |
| UTHR | UNITED THERAPEUTICS CORP | 39,959 | $9.416M | 3.5% | $137.04 | +48.3% | COM | 91307C102 |
| BHC | BAUSCH HEALTH COMPANIES INC | 1,042,700 | $8.717M | 3.3% | $13.98 | 0.0% | Put | 071734107 |
| — | INARI MEDICAL INC | 112,466 | $7.647M | 2.9% | $76.09 | — | COM | 45332Y109 |
| BIIB | BIOGEN INC | 35,900 | $7.321M | 2.7% | $204.43 | 0.0% | COM | 09062X103 |
| MDT | MEDTRONIC PLC | 80,000 | $7.18M | 2.7% | $90.37 | 0.0% | SHS | G5960L103 |
| SGHT | SIGHT SCIENCES INC | 724,944 | $6.517M | 2.4% | $8.80 | 0.0% | COM | 82657M105 |
| — | NATUS MEDICAL INC | 190,956 | $6.258M | 2.4% | $25.12 | — | COM | 639050103 |
| CAH | CARDINAL HEALTH INC | 119,061 | $6.223M | 2.3% | $52.64 | 0.0% | COM | 14149Y108 |
| THC | TENET HEALTHCARE CORP | 105,000 | $5.519M | 2.1% | $69.59 | 0.0% | COM NEW | 88033G407 |
| VNDA | VANDA PHARMACEUTICALS INC | 488,965 | $5.33M | 2.0% | $11.29 | -8.2% | COM | 921659108 |
| — | BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD | 35,000 | $5.1M | 1.9% | $145.71 | — | COM | G11196105 |
| SKIN | THE BEAUTY HEALTH COMPANY | 362,294 | $4.659M | 1.7% | $13.40 | 0.0% | COM CL A | 88331L108 |
| — | INHIBRX INC | 365,210 | $4.145M | 1.6% | $15.07 | — | COM | 45720L107 |
| UHS | UNIVERSAL HEALTH SERVICES INC | 40,725 | $4.101M | 1.5% | $122.89 | 0.0% | CL B | 913903100 |
| — | HESKA CORP | 39,566 | $3.739M | 1.4% | $94.50 | — | COM RESTRC NEW | 42805E306 |
| — | POINT BIOPHARMA GLOBAL INC | 504,545 | $3.436M | 1.3% | $5.90 | — | COM | 730541109 |
| — | HORIZON THERAPEUTICS PUB L | 40,000 | $3.19M | 1.2% | $79.75 | — | SHS | G46188101 |
| MODD | MODULAR MEDICAL INC | 574,352 | $2.975M | 1.1% | $4.57 | 0.0% | COM NEW | 60785L207 |
| VKTX | VIKING THERAPEUTICS INC | 999,829 | $2.89M | 1.1% | $6.74 | -63.3% | COM | 92686J106 |
| — | PROMETHEUS BIOSCIENCES INC | 101,600 | $2.868M | 1.1% | — | — | Put | 74349U108 |
| — | EUCRATES BIOMEDICAL ACQUISITION CORP. | 248,674 | $2.492M | 0.9% | $10.66 | — | UNIT 10/23/2027 | G3141W114 |
| — | HEALTH SCIENCES ACQUISITIONS CORP 2 | 250,000 | $2.49M | 0.9% | $11.00 | — | ORD SHS | G4411D109 |
| — | AEGLEA BIO THERAPEUTICS INC | 4,668,536 | $2.358M | 0.9% | $1.46 | — | COM | 00773J103 |
| — | AFFIMED NV | 821,065 | $2.274M | 0.9% | $4.02 | — | COM | N01045108 |
| — | MERUS NV | 87,953 | $1.991M | 0.7% | $31.80 | — | COM | N5749R100 |
| — | CYMABAY THERAPEUTICS INC | 555,610 | $1.639M | 0.6% | $3.37 | — | COM | 23257D103 |
| — | PRECISION BIOSCIENCES INC | 1,008,993 | $1.614M | 0.6% | $1.60 | — | COM | 74019P108 |
| — | MOLECULIN BIOTECH INC | 1,036,853 | $1.503M | 0.6% | $4.03 | — | COM | 60855D200 |
| — | RENOVACOR INC | 735,908 | $1.492M | 0.6% | $9.05 | — | COM | 75989E106 |
| SVRA | SAVARA INC | 856,428 | $1.302M | 0.5% | $1.21 | +8.5% | COM | 805111101 |
| ANIP | ANI PHARMACEUTICALS INC | 40,000 | $1.187M | 0.4% | $42.97 | -32.9% | COM | 00182C103 |
| — | ALBIREO PHARMA INC | 58,556 | $1.163M | 0.4% | $33.37 | — | COM | 01345P106 |
| TYRA | TYRA BIOSCIENCES INC | 152,159 | $1.088M | 0.4% | $10.81 | -26.4% | COM | 90240B106 |
| — | PARDES BIOSCIENCES INC | 315,564 | $969K | 0.4% | $16.28 | — | COM | 69945Q105 |
| — | NEUBASE THERAPEUTICS INC | 906,445 | $952K | 0.4% | $6.16 | — | COM | 64132K102 |
| — | ISOPLEXIS CORP | 407,102 | $879K | 0.3% | $9.19 | — | COM | 465005106 |
| — | IVERIC BIO INC | 86,400 | $831K | 0.3% | — | — | Put | 46583P102 |
| — | FUSION PHARMACEUTICALS INC | 260,448 | $649K | 0.2% | $11.22 | — | COM | 36118A100 |
| — | ASLAN PHARMACEUTICALS LTD | 1,270,758 | $629K | 0.2% | $1.92 | — | ADS | 04522R101 |
| — | NEXTCURE INC | 130,000 | $611K | 0.2% | $6.00 | — | COM | 65343E108 |
| — | CONNECT BIOPHARMA HOLDINGS LTD | 597,678 | $520K | 0.2% | $3.02 | — | ADS | 207523101 |
| — | ELEVATION ONCOLOGY INC | 359,731 | $504K | 0.2% | $4.95 | — | COM | 28623U101 |
| XENE | XENON PHARMACEUTICALS INC | 16,368 | $498K | 0.2% | $29.94 | +1.0% | COM | 98420N105 |
| — | CYCLACEL PHARMACEUTICALS INC | 454,355 | $491K | 0.2% | $5.57 | — | COM | 23254L603 |
| ARDX | ARDELYX INC | 692,357 | $408K | 0.2% | $0.74 | 0.0% | COM | 039697107 |
| — | X4 PHARMACEUTICALS INC | 276,909 | $267K | 0.1% | $8.61 | — | COM | 98420X103 |
| NYXH | NYXOAH SA | 16,110 | $148K | 0.1% | $31.50 | -53.4% | SHS | B6S7WD106 |
| — | VINCERX PHARMA INC | 102,049 | $135K | 0.1% | $18.89 | — | COM NEW | 92731L106 |
| — | CAREMAX INC | 30,741 | $112K | 0.0% | $10.54 | — | COM CL A | 14171W103 |
| BHC | BAUSCH HEALTH COMPANIES INC | 6,700 | $56,000 | 0.0% | $13.98 | 0.0% | COM | 071734107 |
| HUMAW | HUMACYTE INC | 49,998 | $45,000 | 0.0% | $2.90 | — | *W EXP 09/21/202 | 44486Q111 |
| — | NEOLEUKIN THERAPEUTICS INC | 38,312 | $39,000 | 0.0% | $12.32 | — | COM | 64049K104 |
| — | RENOVACOR INC | 400,000 | $34,000 | 0.0% | $0.69 | — | *W EXP 99/99/999 | 75989E114 |
| — | CAREMAX INC | 12,808 | $9,000 | 0.0% | $2.81 | — | *W EXP 06/08/2026 | 14171W111 |